A 16-year-old boy hailing from Kalaburagi, who was declared blind and was provided a blind certificate, has now got the gift of vision through a free advanced surgery and treatment at a private hospital in Bengaluru.
The boy, Ganesh (name changed), had been complaining ofprogressive worsening of vision in both eyes since he was aged three. However, owing to financial constraints, his family could not get him timely treatment.
He came to Sankara Eye Hospital in the city through the hospitals Gift of Vision initiative. On examination, the boy was diagnosed with severe retinal detachment complications with numerous retinal angiomas and associated scarring, specific for a condition known as Von-Hippel Lindau disease (VHL).
VHL is a hereditary condition associated with tumours arising in multiple organs mainly in the brain, spinal cord and retina. This genetic disorder has a high risk of getting transmitted to the children. Following a detailed discussion with the family members, doctors learnt that theboys grandmother was the only surviving member of the family. The boys parents and two siblings had succumbed to the disease a few years back. VHL as a disease can be catastrophic not only to the patient but also to the entire family.
After having made the diagnosis, a team of doctors under the supervision ofMahesh Shanmugam, Head Ocular Oncology and Vitreoretinal diseases, atthe hospital successfully performed the surgery free of cost. Through the surgery, the doctors fixed the complicated retinal detachment and also treated the multiple tumours with laser therapy to prevent them from causing any further damage to the eye. The boy was able to see within two weeks after the surgery and is now leading a near normal life.
More:
Teen declared blind regains sights with free advanced treatment in Bengaluru - The Hindu
- 001 Early changes in photopic negative response in eyes with glaucoma with and without choroidal detachment after filtration surgery - British Journal of... [Last Updated On: April 11th, 2022] [Originally Added On: April 11th, 2022]
- 002 ViGeneron signs gene therapy strategic collaboration and option agreement with Regeneron for one inherited retinal disease target - BioSpace [Last Updated On: April 11th, 2022] [Originally Added On: April 11th, 2022]
- 003 Ocular Gene Therapy: Immune and Inflammatory Responses | OPTH - Dove Medical Press [Last Updated On: June 8th, 2022] [Originally Added On: June 8th, 2022]
- 004 Impact of the COVID-19 Pandemic on the Incidence and Characteristics o | OPTH - Dove Medical Press [Last Updated On: August 11th, 2022] [Originally Added On: August 11th, 2022]
- 005 Ocuphire Extends U.S. Patent Protection for Late-Stage Drug Candidate Nyxol for Reversal of Mydriasis by Five More Years into 2039 with New Patent... [Last Updated On: August 11th, 2022] [Originally Added On: August 11th, 2022]
- 006 Trabeculectomy: Does It Have a Future? - Cureus [Last Updated On: August 11th, 2022] [Originally Added On: August 11th, 2022]
- 007 Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid... [Last Updated On: August 11th, 2022] [Originally Added On: August 11th, 2022]
- 008 Posterior vitreous detachment - Wikipedia [Last Updated On: October 31st, 2022] [Originally Added On: October 31st, 2022]
- 009 Oxygen toxicity - Wikipedia [Last Updated On: October 31st, 2022] [Originally Added On: October 31st, 2022]
- 010 Retinal Detachment: Symptoms, Causes & Prevention - Cleveland Clinic [Last Updated On: October 31st, 2022] [Originally Added On: October 31st, 2022]